Detalles de la búsqueda
1.
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer.
Tumour Biol
; 46(s1): S327-S340, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37270827
2.
Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients.
Int J Mol Sci
; 24(17)2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686200
3.
Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
Br J Cancer
; 126(3): 409-418, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848855
4.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Lancet Oncol
; 22(12): 1681-1691, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34767759
5.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
N Engl J Med
; 376(25): 2415-2426, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28636851
6.
Single tube liquid biopsy for advanced non-small cell lung cancer.
Int J Cancer
; 144(12): 3127-3137, 2019 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536653
7.
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Lancet Oncol
; 23(7): 833-835, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483383
8.
Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.
Carcinogenesis
; 38(2): 144-151, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27993895
9.
Management of immune checkpoint inhibitor-induced polymyalgia rheumatica.
Ann Rheum Dis
; 81(12): e263, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887684
10.
Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.
Ann Rheum Dis
; 81(10): e210, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241799
11.
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy.
Cancer Immunol Res
; 12(6): 759-778, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573707
12.
The additional diagnostic value of virtual bronchoscopy navigation in patients with pulmonary nodules - The NAVIGATOR study.
Lung Cancer
; 177: 37-43, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708592
13.
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments.
Cancer Treat Rev
; 120: 102628, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797348
14.
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
J Thorac Oncol
; 18(2): 181-193, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36307040
15.
The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare.
Cancers (Basel)
; 14(14)2022 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884570
16.
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial.
Lung Cancer
; 170: 133-140, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35777160
17.
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.
Clin Lung Cancer
; 23(2): e104-e115, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34325996
18.
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer.
ERJ Open Res
; 8(4)2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267895
19.
Detection and localization of early- and late-stage cancers using platelet RNA.
Cancer Cell
; 40(9): 999-1009.e6, 2022 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055228
20.
A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker.
Lung Cancer
; 154: 13-22, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33607458